NCT07081295

Brief Summary

The electrical impedance tomography (EIT) is a bedside, non-invasive, non-radiation imaging tool for lung mornitoring. Currently, the EIT saline-contrast method for lung perfusion evaluation has been widely used in clinical. However, this technique requires the patient to hold breath for 8-30s to avoid the respiratory interference. Hence, it is not suitable for patients that can not tolerate breath hold or unable to maintain a steady apnoea. This study aims to develop an algorithm system based on low frequency band pass filter for EIT saline-contrast lung perfusion estimation without ventilation interruption, and investigate the correlation and agreement of EIT results between the novel method and the conventional breath-hold method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2024

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 2, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

1 month

First QC Date

July 2, 2025

Last Update Submit

July 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Regional V/Q match

    Offline analysis, immediately after the saline injection procedure

Secondary Outcomes (1)

  • Pixel-wise lung perfusion fraction

    Offline analysis, immediately after the saline injection procedure

Study Arms (2)

No apnea group

EXPERIMENTAL

First, perform the EIT saline contrast method without apnea. After a 10-minute washout period, perform the conventional saline contrast method with apnea.

Other: Injection of hypertonic saline

Apnea group

OTHER

First, perform the conventional EIT saline contrast method with apnea. After a 10-minute washout period, perform the saline contrast method without apnea.

Other: Injection of hypertonic saline

Interventions

Injection 10 mL of 10% NaCl through central venous catheter

Apnea groupNo apnea group

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In need of lung perfusion assessment due to clinical condition
  • With central venous catheter

You may not qualify if:

  • Pregnant or breastfeeding females
  • contraindications to the use of EIT (automatic implantable cardioverter defibrillator, chest wounds limiting electrode belt placement, implantable pumps, etc.)
  • severe hyperchloremia (\>155 mmol/L)
  • unable to tolerate breath-hold maneuver
  • edema disease (nephrotic syndrome, cirrhotic ascites, congestive heart failure, etc.)
  • Patients with severe hypernatraemia or hyperchloremia and severe hypertonicity
  • Hypertension (\>160/100 mmHg), hypokalaemia (\> 3.5 mmol/L)
  • Acute renal failure in oliguric stage, chronic renal failure with reduced urine output and poor response to diuretics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

MeSH Terms

Conditions

Lung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2025

First Posted

July 23, 2025

Study Start

September 10, 2024

Primary Completion

October 10, 2024

Study Completion

October 15, 2024

Last Updated

July 23, 2025

Record last verified: 2025-07

Locations